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ABSTRACT 
Previous research indicates that serotonin (5-HT) enhances the acquisition of 
stress-induced changes in behavior; although it is unclear which serotonin 
receptors mediate this enhancement. 5-HT2 receptors are potential candidates 
because activation at these receptors is associated with increased fear and 
anxiety. In this study we investigated whether pharmacological treatments 
targeting 5-HT2A and 5-HT2C receptors modulated the acquisition and 
expression of conditioned defeat. Conditioned defeat is a social defeat model in 
Syrian hamsters (Mesocricetus auratus) that is characterized by increased 
submissive and defensive behavior and a loss of territorial aggression following 
social defeat. In experiment 1, we injected the 5-HT2C receptor agonist mCPP 
(0.3, 1.0, or 3.0 mg/kg) or vehicle prior to social defeat and tested subjects for 
conditioned defeat behavior in a social interaction test 24 hours later. In 
experiment 2, subjects received a social defeat, and 24 hours later we injected 
mCPP (0.3, 1.0, or 3.0 mg/kg) or vehicle prior to a social interaction test. We 
found that injection of mCPP increased the expression, but not acquisition, of 
conditioned defeat. In experiment 3, we injected the 5-HT2A receptor antagonist 
MDL 11,939 (0.5 or 2.0 mg/kg) or vehicle prior to a social defeat and tested 
subjects for conditioned defeat behavior. In experiment 4, subjects received a 
social defeat, and 24 hours later we injected MDL 11,939 (0.5 or 2.0 mg/kg) or 
vehicle prior to a social interaction test. We found that injection of MDL 11,939 
significantly decreased the acquisition, but not expression, of conditioned defeat. 
These data suggest that pharmacological activation of 5-HT2C receptors 
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enhances the expression of conditioned defeat, while pharmacological blockade 
of 5-HT2A receptors impairs the acquisition of conditioned defeat. These data 
extend other studies indicating that 5-HT signaling at 5-HT2A receptors facilitate 
memories for aversive events and 5-HT signaling at 5-HT2C receptors enhance 
stress-induced anxiety.  
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INTRODUCTION 
Psychosocial stress in humans can lead to a variety of psychiatric 
disorders, including major depression, acute stress disorder, and post-traumatic 
stress disorder (Ramboz et al., 1998, Naughton et al., 2000, Middlemiss et al., 
2002, Davidson, 2003). The biological basis for stress-related mental illness 
remains poorly understood. Animal models of fear and anxiety have been used to 
understand the neural mechanisms underlying these psychiatric disorders. 
Because most of the stressors that are experienced by humans are social in 
nature (Brown and Prudo, 1981, Kessler, 1997, Bjorkqvist, 2001), ethologically 
relevant animal models that examine social conflict are particularly useful for 
determining how social experience alters the brain and subsequent behavior. 
Previous research has used physical stressors such as forced swim, foot shock 
and immobilization test. Although these are potent stressors that activate the 
stress response, physical stressors activate slightly different neural circuitry 
compared to psychosocial stressors (Canteras and Blanchard, 2008). 
Social defeat is a robust stressor that activates the HPA-axis (Blanchard 
et al., 1995, Koolhaas et al., 1997). Social defeat also leads to several long-
lasting behavioral and physiological changes, such as decreased locomotor 
activity /exploratory behavior (Meerlo et al., 1996a, Koolhaas et al., 1997, Rygula 
et al., 2005), changes in circadian rhythmicity  (Meerlo et al., 1996a, Meerlo et 
al., 2002) and altered feeding and body weight (van de Poll et al., 1982, Meerlo 
et al., 1996b, Bartolomucci et al., 2004, Foster et al., 2006). The behavioral 
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effects produced by social defeat stress are noticeably similar to symptoms of 
depression, and many of these effects are reversed with antidepressant 
treatments (e.g., drugs or controlled sleep deprivation) (Fuchs et al., 1996, 
Meerlo et al., 1996a, Berton et al., 1999). Social defeat also produces changes in 
the serotonergic system. Serotonin’s (5-HT’s) specific role in fear and anxiety-like 
behavior is mixed. Conflicting data from human and animal research support 
both an anxiolytic and anxiogenic role for 5-HT (Gordon and Hen, 2004). More 
research is being conducted on various 5-HT receptors that may be mediating 
the changes in anxiety behavior. 
Siberian and Syrian hamsters have been used as rodent models in 
circadian rhythms, obesity, and agonistic behavior (Wade and Bartness, 1984a, 
b). Syrian hamsters are especially useful for studying changes in agonistic 
behavior because they are solitary aggressive animals that will defend their 
territory from conspecifics (Nowack and Paradiso 1983). In a laboratory setting, 
singly housed hamsters defend their territory from intruders who are placed in 
their home cage (Albers 2002). However if a Syrian hamster loses an aggressive 
encounter, it will fail to display its’ natural territorial aggression in future 
encounters and instead display submissive and defensive behavior towards a 
novel intruder (Huhman et al., 2003). This switch in agonistic behavior has been 
called conditioned defeat and has been used as a model for stress-induced 
anxiety disorders (Huhman, 2006). 
Stressful events are known to increase fear and anxiety. Exposure to a 
predator is an ethologically relevant stressor that causes an increase in flight, 
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avoidance, and risk assessment in a mouse defensive test battery (Blanchard et 
al., 1990, Griebel et al., 1995). Predator odor increases different types of 
defensive behavior in both mice and rats depending on whether the threat is 
uncertain, distal, or proximal (Blanchard and Blanchard 2008). For instance, rats 
perform cautious exploration, such as risk assessment, in novel environments, 
when danger is certain. When a predator is perceived at a distance, tense and 
attentive immobility (freezing) ensues. Finally, when a predator is near or in 
actual contact with the rat, the animal flees whenever possible or otherwise 
threatens back or even attacks the predator defensively (Blanchard and 
Blanchard, 1988). Our lab has attempted to differentiate these defensive 
behaviors in hamsters by quantifying flight as a fear-like response, and stretch 
attends as an anxiety-like response. 
Serotonin (5-HT) I a neurochemical increased during stressful events and 
known to modulate fear and anxiety. Previous research suggests that disruption 
of 5-HT is linked to anxiety disorders and serotonergic drugs are used as 
pharmacological treatment for many anxiety disorders (Owens and Nemeroff, 
1998, Ballenger, 1999). The majority of 5-HT neurons that innervate stress-
sensitive regions of the forebrain project from the dorsal raphe nucleus (DRN). 
Increases in 5-HT concentrations in the DRN are associated with exposure to 
stressful stimuli such as forced swim (Kirby et al., 1995) and foot shock 
(Yoshioka et al., 1995). 5-HT has been shown to increase anxiety in conflict tests 
in rats tested in an elevated t-maze (Graeff, 2002). Our lab has shown that social 
defeat activates 5-HT neurons in the DRN (Cooper et al., 2009). Additionally, we 
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have shown that blocking 5-HT activity by activating 5-HT1A autoreceptors in the 
DRN disrupts the acquisition and expression of conditioned defeat (Cooper et al., 
2008).  
 It is unclear which 5-HT receptors in the forebrain facilitate stress-induced 
changes in fear and anxiety. 5-HT2 receptors are potential candidates for 
translating stress-induced increases in 5-HT into increased anxiety-like behavior. 
5-HT2 receptors are postsynaptic, G-protein coupled receptors, that elevate 
cytosolic Ca++ (Conn and Sanders-Bush, 1986). The three subtypes of 5-HT2 
receptors (2A, 2B, and 2C) have different distributions in the brain. While 5-HT2B 
receptors are found mainly in the periphery, 5-HT2A and 5-HT2C receptors are 
widely distributed throughout the brain. 5-HT2A receptors occur in high densities 
in the frontal cortex, piriform cortex, ventro-caudal part of the hippocampus 
(CA3), medial mammilary nucleus, the pontine nuclei, the motor cranial nerve 
nuclei in the brainstem, and the ventral horn of the spinal cord (Pompeiano et al., 
1994). High densities of 5-HT2C receptors are found in retrosplenial, piriform and 
entorhinal cortex, anterior olfactory nucleus, lateral septal nucleus, subthalamic 
nucleus, amygdala, subiculum and ventral part of CA3, lateral habenula, 
substantia nigra pars compacta, several brainstem nuclei and the whole grey 
matter of the spinal cord (Pompeiano et al., 1994). 5-HT2C receptors contribute 
to the expression of fear and anxiety. Pharmacological activation of 5-HT2C 
receptors has induced panic attacks in humans (Kahn et al., 1988). 
Administration of a 5-HT2C receptor agonist before testing has been shown to 
increase the expression of learned helplessness behavior, such as reduced 
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social exploration, in rats (Strong et al., 2009). 5-HT2A receptors are important 
for the formation of emotional memories.  Injection of 5-HT2A receptor agonists 
prior to training has been shown to facilitate eye blink conditioning in rabbits 
(Harvey, 2003). 
The purpose of this study was to examine the role of 5-HT2A and 5-HT2C 
receptors in conditioned defeat. We chose the drug mCPP, a 5-HT2C receptor 
agonist, because previous research in animal and human studies has shown that 
mCPP increases anxiety. We choose MDL 11,939, a 5-HT2A receptor antagonist 
because of its’ high affinity for 5-HT2A receptors over other 5-HT receptors. We 
hypothesized that 5-HT2C receptor activation prior to testing would increase the 
production of conditioned defeat behavior. Also we hypothesized that 5-HT2A 
receptor blockade prior to social defeat training would impair the formation of 
conditioned defeat. 
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METHODS 
 
Animals 
Subjects were adult male Syrian hamsters (Mesocricetus auratus) that 
weighed 130–190 g (3–4 months) at the start of the study, and were individually 
housed for 10–14 days prior to testing. Older hamsters that weighed 180–200 g 
(>6 months) were individually housed and used as resident aggressors for social 
defeat training. Immature hamsters that weighed 90–120 g (2 months) were 
group-housed (three or four animals per cage) and used as non-aggressive 
opponents for conditioned defeat testing. All animals were housed in 
polycarbonate cages (20 cm × 40 cm × 20 cm) with corncob bedding, cotton 
nesting materials, and wire mesh tops. Animal cages were not changed for at 
least 1 week prior to testing to allow individuals to scent mark their territory. 
Animals were housed in a temperature-controlled colony room (20 ± 2 °C) and 
maintained on a 14:10 h light-dark cycle with food and water available ad libitum. 
All procedures were approved by the University of Tennessee Animal Care and 
Use Committee and are in accordance with the US National Institutes of Health 
Guide for the Care and Use of Laboratory Animals.  
 
Conditioned defeat protocol 
During social defeat training subjects experienced either one 15-min or 
one sub-optimal 10-min aggressive encounter in a resident aggressor's home-
cage. The 10-min aggressive encounters were used to avoid a ceiling effect 
when we expected drug treatment to increase conditioned defeat behavior. 
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During social defeat training subjects were reliably attacked and defeated by 
resident aggressors. To standardize the amount of aggression received and the 
duration of social defeat, timing of aggressive encounters began at the first attack 
by the resident aggressor, which usually occurred within the first 60 s. During 
social defeat training we recorded the total duration of aggression and the 
number of attacks displayed by resident aggressors. No-defeat control subjects 
did not receive a social defeat. To investigate whether drug treatments affected 
agonistic behavior in the absence of social defeat experience, we included no-
defeat control groups that were exposed to a resident aggressor's empty cage. 
We performed all training and subsequent testing under red or dim light (< 40 lux) 
during the first 3 h of the dark phase of the light-dark cycle. 
Behavioral testing occurred 24 h after training and consisted of one, 5-min 
encounter with a novel, non-aggressive opponent in the subject's home cage. 
Testing sessions were digitally recorded and later scored by researchers blind to 
the experimental conditions using an ethogram adapted from Albers et al.(2002).  
A second researcher scored a subset of testing sessions; inter-observer reliability 
was 91% with a kappa of coefficient of .292. We recorded the total duration of 
four classes of behavior during the 5-min tests: (a) non-agonistic social 
(approach, investigate, sniff, and nose touch); (b) nonsocial (locomotion, 
exploration, self-groom, nest build, and feed); (c) submissive and defensive 
(flight, avoid, tail up, upright and side defense, full submissive posture, stretch-
attend, head flag, attempt to escape from cage); and (d) aggressive (upright and 
side offense, chase, and attack including bite). For a more detailed analysis of 
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the subject's agonistic behavior, we also quantified the frequency of flight, 
stretch-attend, and attack.  
 
Drugs 
We dissolved 1-(3-Chlorophenyl)piperazine (mCPP; Sigma-Aldrich) in 
sterile saline as per previous research (Fox at al. 2008). mCPP is a non-selective 
5-HT2 receptor agonist which shows a preferential affinity at 5-HT2C receptors 
(Kimura et al., 2009). We dissolved α-phenyl-1-(2-phenylethyl)-4-piperidine 
methanol (MDL 11,939; Tocris) in sterile saline with 1% of acetic acid and 
adjusted the pH to 5.5 with NAOH as per previous research (Welsh et al., 1998). 
MDL 11,939 is a highly selective 5-HT2A receptor antagonist (Welsh et al., 
1998). All drugs were administered in a 0.3 ml volume using an intraperitoneal 
injection (i.p.) with a 1ml syringe. 
 
Experiments 1 and 2: 5-HT2C receptor agonist 
We designed experiment 1 to test whether injection of a 5-HT2C receptor 
agonist would enhance the acquisition of conditioned defeat. We injected mCPP 
(0.3 mg/kg, N=11; 1.0 mg/kg, N=11; or 3.0 mg/kg, N=11) or vehicle (N = 11) 
15 min prior to a 10-min social defeat. Animals were tested for conditioned defeat 
behavior 24 h later. 
We designed experiment 2 to test whether injection of a 5-HT2C receptor 
agonist would enhance the expression of conditioned defeat. Hamsters received 
a 10-min social defeat, and 24 hours later we injected mCPP (0.3 mg/kg, N=10; 
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1.0 mg/kg, N=11; or 3.0 mg/kg, N=10) or vehicle (N=11) 15-minutes prior to 
conditioned defeat testing. No defeat controls received exposure to a resident 
aggressor's empty cage during training, and 24 h later we injected mCPP (1.0 
mg/kg, N=8) or vehicle (0.0 mg/kg, N=8) 15-minutes prior to conditioned defeat 
testing. 
 
Experiments 3 and 4: 5-HT2A receptor antagonist 
We designed Experiment 3 to test whether injection of a selective 5-HT2A 
receptor antagonist would reduce the acquisition of conditioned defeat. We 
injected MDL 11,939 (0.5 mg/kg, N=11; or 2.0 mg/kg, N=10) or vehicle (N=10) 
30 min prior to a 15-min social defeat. For no defeat controls, we injected MDL 
11,939 (2.0 mg/kg, N=8) or vehicle (0.0 mg/kg, N=9) 30 min prior to exposure to 
a resident aggressor's empty cage. Animals were tested for conditioned defeat 
behavior 24 h later as described above. 
We designed Experiment 4 to test whether injection of a selective 5-HT2A 
receptor antagonist would reduce the expression of conditioned defeat. Hamsters 
receive a 15-min social defeat, and 24 h later we injected MDL 11,939 (0.5 
mg/kg, N=11; or 2.0 mg/kg, N=10) or vehicle (N=10) 30 min prior conditioned 
defeat testing. Likewise, no defeat controls received exposure to a resident 
aggressor's empty cage during training, and 24 h later we injected MDL 11,939 
(2.0 mg/kg, N=8) or vehicle (0.0 mg/kg, N=8) 30 min prior to conditioned defeat 
testing. 
Data analysis 
10	  	  
Several subjects were not included in statistical analysis because of 
difficulties with the conditioned defeat protocol. Nine animals were excluded 
because they were attacked by intruders during testing, two were excluded 
because of insufficient defeats, and 25 animals were excluded because two 
cohorts of subjects failed to show conditioned defeat behavior. The 2 excluded 
cohorts were bred in the Walters Life Science building at the University of 
Tennessee, Knoxville, born in June and July, and had no obvious reason for not 
showing conditioned defeat. Our lab is currently investigating individual variation 
in our subjects to explain why Syrian hamsters can widely vary in their display of 
conditioned defeat behavior.  We analyzed the data with both cohorts included, 
dropping all animals that did not shown conditioned defeat, and by dropping 
cohorts when vehicle control subjects did not show conditioned defeat and the 
statistical results were similar for all three types of analyses. 
For social defeat training, we analyzed the total duration of aggression 
received by subjects and the frequency of attacks received by subjects. For 
conditioned defeat testing, we separately analyzed the total durations of 
submissive and defensive, non-agonistic social, nonsocial, and aggressive 
behavior, as well as the frequencies of attack, flight, and stretch-attend posture. 
Conditioned defeat data were analyzed using two-way ANOVAs with defeat 
experience (defeat; no defeat) and drug dose as independent variables. To 
investigate a dose-response relationship for drug treatments in defeated subjects 
we performed one-way ANOVAs with Tukey or LSD post-hoc tests.  We used t-
tests to further investigate the effect of drug treatment in no defeat controls. All 
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statistical tests were two-tailed and the alpha level was p < 0.05. Data are 
presented as mean ± S.E. 
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RESULTS 
Experiment 1: mCPP and acquisition of conditioned defeat 
Injection of mCPP prior to social defeat did not significantly alter the 
acquisition of conditioned defeat (Fig 1). mCPP treatment did not significantly 
alter the duration of submissive and defensive behavior (F(3,43) = 0.279, 
p = 0.840). Likewise, animals injected with 0.3, 1.0 or 3.0 mg/kg of mCPP did not 
show significant changes in frequency of flight (F(3,43) = 1.177, p = 0.330) or 
stretch-attend postures (F(3,43) = .320, p = 0.811) compared to vehicle controls 
(Table 1). Injection of mCPP prior to social defeat did not alter the duration of 
non-agonistic social behavior (F(3,43) = .390, p = 0.760), nonsocial behavior 
(F(3.43) = .346, p = 0.792),   or aggressive behavior (F(3,43) = 1.306, p = 0.286).  
Injection of mCPP prior to social defeat training did not alter the amount of 
aggression resident aggressors directed toward subjects. Vehicle controls 
received 200.5 s (±33.3) of aggression during social defeat and individuals 
injected with 0.3, 1.0, or 3.0 mg/kg of mCPP received 250.5 s (±28.9), 291.5 
(±24.6) and 296.0 s (±28.4) of aggression, respectively (F(3,43) = 0.55, p = 0.567). 
Vehicle controls received 12.3 (±1.1) attacks during social defeat and individuals 
injected with 0.3, 1.0 and 3.0 mg/kg of mCPP received 10.8 (±1.6), 13.7 (±2.1) 
and 12.7 (±1.9), attacks, respectively (F(3,43) = 1.41, p = 0.796).  
 
Experiment 2: mCPP and expression of conditioned defeat 
Injection of mCPP prior to behavioral testing dose dependently increased 
the expression of conditioned defeat (Fig 2). A nearly significant drug by defeat 
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interaction (F(1,36) = 4.116, p = 0.051) was found for the duration of submissive 
and defensive behavior. This result indicates that 1.0 mg/kg of mCPP increased 
submissive and defensive behavior in defeated subjects, but not in no defeat 
controls. Also, a one-way ANOVA on defeated subjects showed a significant 
increase in submissive and defensive behavior at 1.0 mg/kg mCPP 
(F(3,40) = 4.204, p = 0.012, Tukey, p = .011) but not at 3.0 mg/kg (Tukey, p = ???). 
However, mCPP did not significantly change the frequency of flight (F(1,36) = .216, 
p = 0.645) or stretch-attend postures (F(1,36) = .430, p = 0.517) compared to 
vehicle controls (Table 2). To measure the selectivity of mCPP’s effect on 
conditioned defeat behavior we also quantified three other classes of behavior, 
non-agonistic social, nonsocial, aggressive behavior. We expect a selective 
effect of mCPP on submissive/defensive behavior but not on the other classes of 
behavior. Our results were as expected, injection of mCPP prior to behavioral 
testing did not alter the duration of other classes of behavior such as non-
agonistic social (F(1,36) = 0.081, p = 0.778), nonsocial (F(1,36) = 1.270, p = 0.268), 
or aggression (F(1,36) = 0.515, p = 0.478). 
No defeat controls did not show greater aggression (F(1,36) = .515, 
p = 0.478) but did show less submissive and defensive behavior (F(1,36) = 17.382, 
p < 0.001)  compared to defeated subjects (Fig. 2). Also, injection of mCPP in no 
defeat control animals did not alter the duration of submissive and defensive 
(t = -1.260, p = 0.248), aggressive (t = 1.000, p = .351), non-agonistic social (t = 
.476, p = .649), or nonsocial behavior (t = -.643, p = .541). Similarly, no defeat 
controls injected with mCPP or vehicle did not significantly differ in the number of 
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attacks initiated during conditioned defeat testing (t = 1.000, p = .351; Table 2).  
 
Experiment 3: MDL 11,939 and acquisition of conditioned defeat 
Injection of MDL 11,939 prior to social defeat dose dependently decreased 
the acquisition of conditioned defeat (Fig 3). We found significant drug by defeat 
interaction (F(1,36) = 4.793, p = 0.036) was found for the duration of submissive 
and defensive behavior. This result indicates that 2.0 mg/kg of MDL 11,939 
reduced submissive and defensive behavior in defeated subjects, but not in no 
defeat controls. However, a one-way ANOVA on defeated subjects showed a 
marginally significant decrease in submissive and defensive behavior at 2.0 
mg/kg (F(1,30) = 2.594, p = 0.093, LSD, p = .05). MDL 11,939 did not significantly 
change the frequency of flight (F(1,36) = .378, p = 0.543) or stretch-attend postures 
(F(1,36) = .757, p = 0.391) compared to vehicle controls (Table 3). Also, injection of 
MDL 11,939 prior to social defeat did not alter the duration of other classes of 
behavior such as non-agonistic social (F(1,36) = 0.204, p = 0.661), nonsocial 
(F(1,36) = 0.012, p = 0.912), or aggression (F(1,36) = 0.196, p = 0.661). 
No defeat controls showed greater aggression (F(1,36) = 9.412, p = 0.004) 
and less submissive and defensive behavior at testing (F(1,36) = 17.945, 
p = 0.000) compared to defeated subjects (Fig. 3). However, injection of MDL 
11,939 in no defeat control animals did not alter the duration of submissive and 
defensive (t(1,36)  = 1.174, p = 0.279), aggressive (t (1,36) = .417, p = .689), non-
agonistic social (t (1,36) = -.361, p = .729), or nonsocial behavior (t (1,36) = -.203, p 
= .845). Similarly, no defeat controls injected with MDL 11,939 or vehicle did not 
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significantly differ in the number of attacks displayed during conditioned defeat 
testing (t (1,36) = .403, p = .699; Table 3).  
Injection of MDL 11,939 did not alter the level of aggression subjects 
received during social defeat training. Vehicle controls received 307 s (±57.9) of 
aggression during social defeat and individuals injected with 0.5 or 2.0 mg/kg of 
MDL 11,939 received 303 s (±47.5) and 277.3 s (±53.3), respectively 
(F(2,28) = 0.095, p = 0.909). Vehicle controls received 21.7 (±1.2) attacks during 
social defeat and individuals injected with 0.5 or 2.0 mg/kg of MDL 11,939 
received 19.5 (±2.5)and 16.4 (±3.3), attacks, respectively (F(2,28) = 0.857, 
p = 0.436).  
 
Experiment 4: MDL 11,939 and expression of conditioned defeat 
Injection of MDL 11,939 prior to behavioral testing did not significantly 
alter the expression of conditioned defeat (Fig 4). We did not find a significant 
drug by defeat interaction for the duration of submissive and defensive behavior 
(F(1,37) = 0.98, p = 0.757). Also, a one-way ANOVA on defeated subjects did not 
reveal a significant difference in submissive and defensive behavior 
(F(1,31) = 0.248, p = 0.782). Likewise, animals injected with 0.5 or 2.0 mg/kg of 
MDL 11,939 did not show significant changes in frequency of flight 
(F(1,37) = 0.287, p = 0.837) or stretch-attend postures (F(1,37) = 1.400, p = 0.245) 
compared to vehicle controls (Table 4). Injection of MDL 11,939 prior to 
conditioned defeat testing did not produce changes in the duration of non-
agonistic social behavior (F(1,37) = 1.227, p = 0.276) or aggressive behavior 
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(F(1,37) = 0.314, p = 0.579). However we found a significant drug by defeat 
interaction for nonsocial behavior (F(1,37) = 4.672, p = 0.038), but a one-way 
ANOVA on defeated subjects did not show a significant effect of drug treatment 
on nonsocial behavior (F(2,31) = 2.619, p = 0.090). The modest increase in 
nonsocial behavior appears related to increased cage climbing, nest building, 
and self-grooming and is not directly attributed to drug-induced hyper-locomotion. 
No defeat controls showed elevated aggression (F(1,37) = 5.309, p = 0.027) 
and reduced submissive and defensive behavior (F(1,37) = 10.354, p = 0.003) 
compared to defeated subjects (Fig. 4). Also, injection of MDL 11,939 in no 
defeat control subjects did not alter the duration of aggression (t (1,36) = 1.052, p = 
.328), submission (t (1,36)  = .037, p = .971), non-agonistic social (t (1,36) = -.361, p 
= .729), or nonsocial behavior (t (1,36)   = -.203, p = .845). Similarly, no defeat 
controls attacked non-aggressive opponents at testing more often than did defeat 
animals (F(1,37) = 5.309, p = 0.027), although MDL 11,939 injection did not alter 
frequency of attacks (t (1,36)  = 1.055, p = .326; Table 4). 
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DISCUSSION 
In each experiments we found an effect of social defeat on conditioned 
defeat behavior. Specifically, defeated animals show increased submissive and 
defensive behavior and decrease in aggressive behavior, when compared to no 
defeat control subjects. Also, in all experiments pharmacological manipulations 
did not produce a significant change in the behavior of no defeat subjects. 
Because the effects of drug treatment were limited to defeated subjects, we 
concluded the prior psychosocial stress is required for the 5-HT2 ligands used 
here to modulate agonistic behavior. Our study shows that administration of 
mCPP, a nonselective 5-HT2C receptor agonist, increases the expression but 
not acquisition of conditioned defeat behavior. These results suggest that 
activation of 5-HT2C receptors are important for the production of submissive 
and defensive behavior at testing but not the development of conditioned defeat 
behavior. We found that injection of MDL 11,939, a selective 5-HT2A receptor 
antagonist, reduces the acquisition but not expression of conditioned defeat 
behavior. These results suggest that 5-HT2A receptor blockade impairs the 
development of conditioned defeat but is not critical for the production of 
submissive and defensive behavior at testing. Together these data suggest that 
5-HT may act at 5-HT2C and 5-HT2A receptors to facilitate the expression and 
acquisition of conditioned defeat, respectively. In sum, these results support our 
overarching hypothesis that defeat-induced increases in serotonin act at 5-HT2 
receptors in the forebrain to promote conditioned defeat behavior. 
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Administration of mCPP exacerbates panic attacks in humans with panic 
disorder causing behavioral effects such as increased anxiety, depression and 
panic attacks (Kahn et al., 1988). Also, mCPP increases the expression of 
anxiety-like behavior in several animal models including the social interaction test 
(Bagdy et al., 2001), light/dark transition box test (Bilkei-Gorzo et al., 1998), and 
open field test (Campbell and Merchant, 2003). Although mCPP often is used as 
a 5-HT2C receptor agonist, the drug pharmacology is complex. mCPP activates 
several other receptors and binds with equal affinity to 5-HT2C and 5-HT2B 
receptors. It binds to 5-HT2C receptors with a ten-fold greater selectivity than 5-
HT2A receptors and a two fold greater selectivity than 5-HT1A (Roth et al., 1995, 
Campbell and Merchant, 2003). The non-selective binding of mCPP at 5-HT 
receptors could explain the non-linear dose response curve in our results. We 
found that 1.0 mg/kg of mCPP increased conditioned defeat, whereas 3.0 mg/kg 
was less effective. Our data is consistent with other research showing inverted U-
shaped dose response curves for mCPP effects. For example, mCPP treatment 
increases anxiety in an open field test at doses between 3 and 300 pmol but not 
at 3000 pmol (Campbell and Merchant, 2003). One, possibility is that mCPP fails 
to increase conditioned defeat at high doses because it binds to other receptors, 
such as the 5-HT1A receptor. This possibility would be consistent with our 
previous finding that activation of 5-HT1A receptors in the basolateral amygdala 
(BLA) decreases conditioned defeat (Morrison et al., 2011). In a learned 
helplessness model, another 5-HT2C receptor agonist, CP-809101, has been 
shown to impaire escape behavior in the absence of prior stress (Strong et al., 
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2009). Unlike with Strong et al. (2009), activation of 5-HT2C receptors in our 
study did not create conditioned defeat behavior in our no defeat subjects. Thus, 
activation of 5-HT2C receptors appears to interact with social defeat to enhance 
the display of submissive and defensive behavior, however it does not produce 
conditioned defeat itself.  
We also quantified flees and stretch attends in an attempt to differentiate 
fear and anxiety. Threat stimuli, like predator odor, increases different types of 
defensive behavior in both mice and rats.  These defensive behaviors have been 
divided into fear-like responses, which include escape behavior, and anxiety-like 
behavior, which include risk assessment (Blanchard and Blanchard 2008). In our 
animals we used flees to represent escape behavior and stretch attends to 
represent risk assessment behavior. MDL and mCPP failed to significantly alter 
the frequency of flees or stretch attends. Because there were no significant 
changes in flee or stretch attend behavior our study was unable to differentiate 
the effect of 5-HT2 receptors on this aspect of fear and anxiety. Future research 
will require us to modify our ethogram to more carefully address fearful and 
anxious types of behavior. 
Several brain regions may underlie the effect of mCPP on the expression 
of conditioned defeat.  Brain regions such as the bed nucleus of the stria 
terminalis (BNST) and central nucleus of the amygdala (CeA), have been 
implicated in the link between 5-HT2C receptors and the expression of anxiety 
and fear-like responses. 5-HT2C receptor knock-out mice show reduced c-Fos 
immunoreactivity in the BNST and CeA following exposure to an anxiety-
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provoking stimulus (Heisler et al., 2007). Systemic mCPP administration has 
been shown to increase the expression of c-Fos in the anterolateral BNST 
(Singewald et al., 2003). Also, the anxiogenic effects of mCPP have been linked 
to 5-HT2A/2C receptors expressed by BNST projection neurons (Hammack et 
al., 2009). The BLA is another key brain region because it contains 5-HT2C 
receptor protein (Pompeiano et al., 1994) and plays a critical role in the 
expression of conditioned defeat . Others have found that 5-HT2C receptor 
activation within the BLA causes acute fear-like responses in an open-field test 
(Campbell and Merchant, 2003). Similarly, 5-HT2C receptor activation in the BLA 
reduces social exploration in the learned helplessness model (Christianson et al., 
2010).  
Pharmacological treatments targeting 5-HT2A receptors have been shown 
to modulate several types of learning including spatial, emotional, and 
associative learning in several species (Harvey et al., 1982, Alhaider et al., 1993, 
Williams et al., 2002). Activation of 5-HT2A receptors by lysergic acid 
diethylamide, LSD (Gimpl et al., 1979, Siegel et al., 1996), 2,5-dimethoxy-4-
methylamphetamine, DOM (Harvey et al., 1982), 3,4 
methylenedioxyamphetamine, MDA (Romano et al., 1991), and 
methylenedioxymethamphetamine, MDMA (Romano and Harvey, 1994) 
enhances eye blink conditioning in rabbits. Also blockade of 5-HT2A receptors 
with ritanserin (Welsh et al., 1998), mianserin (Romano et al., 1991), MDL 11,939 
(Welsh et al., 1998), and pizotifen (Ginn and Powell, 1986) has been shown to 
impair eye blink conditioning in rabbits. These studies suggest that 5-HT2A 
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receptor activation facilitates, while 5-HT2A receptor blockade disrupts eye blink 
conditioning. The 5-HT2A receptors’ role in modulating aversive learning is not 
limited to eye blink conditioning in rabbits; other animal and human studies have 
shown that activation or blockade of 5-HT2A receptors modulates the formation 
of memories for aversive events. For example, the acquisition of active 
avoidance was enhanced in rats using quipazine, a 5-HT agonist, and was 
blocked by ketanserin, a 5-HT2A/2C antagonist, suggesting that the enhanced 
formation of active avoidance was facilitated by 5-HT2A receptors (Alhaider et 
al., 1993). Similarly, cyproheptadine, a 5-HT2A/2C receptor antagonist, impaired 
the acquisition of active aviodance (Titov et al., 1983, Ma and Yu, 1993). In 
humans, injection of ritanserin has been shown to impair learning in an aversive 
classical conditioning test (Hensman et al., 1991).  
Consistent with the research on classical conditioning and active 
avoidance, our results support a role for 5-HT2A receptors in the acquisition of 
stress-related memories. Our results indicate that blockade of 5-HT2A receptors 
prior to social defeat impairs the acquisition of conditioned defeat behavior. MDL 
11,939 may impair the acquisition of conditioned defeat by acting in several brain 
regions that have been implicated in emotional memories. 5-HT2A receptors in 
the hippocampus and frontal cortex have been implicated in eye blink 
conditioning (Takehara et al., 2003). Importantly, neural transmission in the 
hippocampus and prefrontal cortex are necessary for the development of 
conditioned defeat. Previous research has shown that inactivation of the 
hippocampus using musicmol disrupted the acquisition of conditioned defeat  
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(Markham et al., 2010) and inactivation of  medial prefrontal cortex impairs 
conditioned defeat resistance in dominant hamsters (Morrison and Cooper, 2010. 
Online). The BLA is another candidate brain region for mediating the effect of 
MDL 11,939 on the development of conditioned defeat. We have previously 
shown that Syrian hamsters have 5-HT2A receptors in the BLA (Morrison et al., 
2011), and neural plasticity in the BLA is critical for the development of 
conditioned defeat (Jasnow et al., 2005, Markham et al., 2010, Day et al., 2011). 
Also, 5-HT2A receptors are present on GABAergic interneurons and 
glutamatergic pyramidal cells in the BLA of rats (McDonald and Mascagni, 2007). 
One possible explanation for our results is that MDL 11,939 may preferentially 
block 5-HT2A receptors on BLA glutamatergic cells and thereby impair the 
development of conditioned defeat. Interesting, serotonergic input can 
desensitize 5-HT2A receptors in vitro (Roth et al., 1995). Thus, another 
possibility is that MDL 11,939 might prevent the desensitization at 5-HT2A 
receptors on GABAergic neurons in the BLA and thus enable serotonergic 
inhibition of the BLA pyramidal neurons at testing (Fig. 5). 
These data extend our understanding the role of 5-HT in the acquisition 
and expression of conditioned defeat.  We have previously shown that enhancing 
5-HT signaling in the DRN increases conditioned defeat (Cooper et al., 2008). It 
was unclear which post-synaptic receptors mediated this increase in conditioned 
defeat. The current study indicates that the 5-HT2 receptors play a key role in 
facilitating conditioned defeat. Our data are consistent with previous research 
suggesting that activation of 5-HT2C receptors is important for the expression of 
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anxiety-like behavior. While the role of 5-HT2A receptors in the acquisition of 
anxiety-like behavior is unclear and our findings provide a novel example of the 
role of 5-HT2A receptors in the formation of anxiety-like behavior. This study 
builds upon our working model of mechanisms by which 5-HT can modulate the 
acquisition and expression of conditioned defeat (see Fig. 5). In sum, our results 
indicate that conditioned defeat is an elegant model for investigating 5-HT’s role 
in anxiety disorders. 
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APPENDIX A 
 
 
Table 1. 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  
Behavior       0.0 mg/kg       0.3 mg/kg       1.0 mg/kg          3.0 mg/kg   p value 
Flee               .455 ± .366     .091 ± .091     1.091 ± .732      .182 ± .122        > .05 
 
Stretch          .364 ± .203      .364 ± .152     .273 ± .141        .545 ± .287        > .05 
Attend 
 
Attack           .000 ± .000      .000 ± .000     .000 ± .000        .545 ± .455        > .05 
The frequencies of flee, stretch attend, and attack (mean ± SE) during 
conditioned defeat testing are shown. All subjects received social defeat and 
were treated with 0.0 mg/kg, 0.3 mg/kg, 1.0 mg/kg, and 3.0 mg/kg of mCPP prior 
to social defeat.  
 
 
 
 	  Table	  2.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Behavior   D 0.0 mg/kg   D 0.3 mg/kg   D 1.0 mg/kg    D 3.0 mg/kg       ND 0.0 mg/kg  ND 1.0 mg/kg   p value 
Flee          1.800 ± .853   1.222± 1.102  1.091 ± .995     .182 ± .122     .000 ± .000       .000 ± .000         > .05 
 
Stretch     .000 ± .000       .111 ± .111      .091 ± .091     .167 ± .167     .000 ± .000      .250 ± .250         > .05 
Attend 
 
Attack      .500 ± .500       .000 ± .000      .000 ± .000     .455 ± .282     .500 ± .500      .000 ± .000          > .05 
The frequencies of flee, stretch attend, and attack (mean ± SE) during 
conditioned defeat testing are shown. Defeated (D) animals were treated with 0.0 
mg/kg, 0.3 mg/kg, 1.0 mg/kg, 3.0 mg/kg of mCPP and No Defeat (ND) animals 
treated with 0.0 mg/kg and 2.0 mg/kg of mCPP did not significantly differ in any 
category of behavior. Subjects received i.p. injection prior to conditioned defeat 
testing. 
 
 
 
 
 
 
 
 
 
 
 
32	  	  
 
 
 Table	  3.	  	  
                  
Behavior   D  0.0 mg/kg   D 0.5 mg/kg   D 2.0 mg/kg   ND 0.0 mg/kg   ND 2.0 mg/kg    p value 
Flee          .400 ± .267     .091 ± .091   .200 ± .267     .200 ± .133        .000 ± .000          > .05 
 
Stretch     .400 ± .163     .182 ± .182    .200 ± .267     .000 ± .000        .000 ± .000         > .05 
Attend 
 
Attack      .000 ± .000      .273 ± .273   .200 ± .200     .556 ± .444        .375 ± .263         > .05 
The frequencies of flee, stretch attend, and attack (mean ± SE) during 
conditioned defeat testing are shown. Defeated (D) animals were treated with 0.0 
mg/kg 0.5 mg/kg, or 2.0 mg/kg of MDL 11,939 prior to social defeat. No Defeat 
(ND) animals were treated with 0.0 mg/kg or 2.0 mg/kg of MDL 11,939 before 
exposure to an aggressor’s empty cage. Subjects did not significantly differ in 
any category of behavior.  
 
 
Table 4. 
 
                 
Behavior  D 0.0 mg/kg   D 0.5 mg/kg   D 2.0 mg/kg     ND 0.0 mg/kg   ND 2.0 mg/kg     p value 
Flee       1 .182 ± 1.086  1.900 ± .824  1.455 ± .824     .000 ± .000        .625 ± .625         > .05 
 
Stretch      .000 ± .000     .300 ± .300    .273 ± .195     .000 ± .000        .000 ± .000         > .05 
Attend 
 
Attack       .000 ± .000      .000 ± .000   .000 ± .000     2.125 ± 1.716     .250 ± .250        = .027 
The frequencies of flee, stretch attend, and attack (mean ± SE) during 
conditioned defeat testing are shown. Defeated (D) animals were treated with 0.0 
mg/kg, 0.5 mg/kg, or 2.0 mg/kg of MDL 11,939 prior to conditioned defeat testing. 
No Defeat (ND) animals were treated with 0.0 mg/kg or 2.0 mg/kg of MDL 11,939 
before conditioned defeat testing. No defeat controls attacked more often than 
did defeat subjects. 
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Figure 1.  Durations (mean ± S.E.) of submissive and defensive, aggressive, 
non-agonistic social, and nonsocial behavior are shown for a 5-minute test with a 
novel, non-aggressive opponent. Subjects received an injection of mCPP (0.3 
mg/kg, N=11; 1.0 mg/kg, N=11; or 3.0 mg/kg, N=11) or vehicle (N=11) 15 min 
before social defeat training.  	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Figure 2.  Durations (mean ± S.E.) of submissive and defensive, aggressive, 
non-agonistic social, and nonsocial behavior are shown for a 5-minute test with a 
novel, non-aggressive opponent. Defeated animals received an injection of 
mCPP (0.3 mg/kg, N=10; 1.0 mg/kg, N=11; or 3.0 mg/kg, N=10) or vehicle 
(N=11) 15 minutes before behavioral testing. Likewise controls received an 
injection of mCPP (1.0 mg/kg, N=8) or vehicle (N=8) 15 minutes before 
behavioral testing. * indicates significantly different than defeated, vehicle 
controls. ** indicates significantly different than defeated subjects. 	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Figure 3.  Durations (mean ± S.E.) of submissive and defensive, aggressive, 
non-agonistic social, and nonsocial behavior are shown for a 5-minute test with a 
novel, non-aggressive opponent. Defeated animals received an injection of MDL 
11,939 (0.5 mg/kg, N=11 or 2.0 mg/kg, N=10) or vehicle 30 minutes before social 
defeat training. Likewise, controls received an injection of MDL 11,939 (2.0 
mg/kg, N=8) or vehicle (N=9) 30 minutes before exposure to a resident 
aggressor’s empty cage. * indicates significantly different than defeated, vehicle 
controls. ** indicates significantly different than defeated subjects. 
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Figure 4.  Durations (mean ± S.E.) of submissive and defensive, aggressive, 
non-agonistic social, and nonsocial behavior are shown for a 5-minute test with a 
novel, non-aggressive opponent. Defeated animals received an injection of MDL 
11,939 (0.5 mg/kg, N=11 or 2.0 mg/kg, N=10) or vehicle (N=10) 30 minutes 
before behavioral testing. Likewise controls received an injection of MDL 11,939 
(2.0 mg/kg, N=8) or vehicle (N=8) 30 minutes before behavioral testing. * 
indicates significantly different than defeated, vehicle controls. ** indicates 
significantly different than defeated subjects. 
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Figure 5. Proposed neural circuit underlying 5-HT1A, 5-HT2A, and 5-HT2C 
receptors role in conditioned defeat behavior. Social defeat activates 5-HT 
neurons in the dorsal raphe nucleus (DRN), in which in turn increases 5-HT 
release into the basolateral amygdala (BLA). 5-HT1A receptor activation in the 
BLA inhibits glutametergic projection cells causing a reduction in the acquisition 
of conditioned defeat behavior. 5-HT2A receptors may facilitate the acquisition of 
conditioned defeat in two separate ways. 5-HT2A receptor activation in the BLA 
may enhance activity of the glutametergic cells projecting to the central 
amygdala, causing an increase in the acquisition of conditioned defeat behavior. 
Also, 5-HT2A receptor activation in the BLA may cause desensitization of 5-
HT2A receptors on GABAergic interneurons and disinhibit glutametergic 
projection cell causing a reduction in conditioned defeat behavior. 5-HT2C 
receptor activation in the central amygdala on glutametergic projection cell may 
an increase the expression of conditioned defeat behavior. 
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